drugset / Trial / NCT00292188

P4 (Pregabalin for Peripheral Posttraumatic Pain)

NCT00292188

Phase 4 Completed 255 enrolled Viatris Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy of pregabalin compared to placebo in the treatment of posttraumatic peripheral neuropathic pain

Timeline

Start
2006-01
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications